Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Flufenazin
2. Fluphenazine
3. Hydrochloride, Fluphenazine
4. Lyogen
5. Prolixin
1. Fluphenazine Dihydrochloride
2. 146-56-5
3. Prolixin
4. Anatensol
5. Permitil
6. Fluphenazine (dihydrochloride)
7. Tensofin
8. Moditen
9. Squibb 4918
10. Dapotum
11. Omca
12. Fluphenazine Hcl
13. Calmansial
14. Flufenazin
15. Lyorodin
16. Liogen
17. Fluphenazine Chloride
18. Fluphenazine Dihcl
19. Fluorophenazine Dihydrochloride
20. Zou145w1xl
21. Valamina
22. 1-(2-hydroxyethyl)-4-(3-(2-trifluoromethyl-10-phenothiazinylpropyl)piperazine Dihydrochloride
23. 1-piperazineethanol, 4-(3-(2-(trifluoromethyl)-10h-phenothiazin-10-yl)propyl)-, Dihydrochloride
24. 4-(3-(2-(trifluoromethyl)phenothiazin-10-yl)propyl)-1-piperazineethanol Dihydrochloride
25. Nsc-179197
26. Trancin
27. A 4077
28. 2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol;dihydrochloride
29. Permitil Hydrochloride
30. 10-(3-(4-(2-hydroxyethyl)piperazinyl)propyl)-2-trifluoromethylphenothiazine Dihydrochloride
31. 1-piperazineethanol, 4-[3-[2-(trifluoromethyl)-10h-phenothiazin-10-yl]propyl]-, Dihydrochloride
32. 2-(4-(3-(2-(trifluoromethyl)-10h-phenothiazin-10-yl)propyl)piperazin-1-yl)ethanol Dihydrochloride
33. Ccris 4032
34. Nsc 62323
35. Sr-01000003048
36. Einecs 205-674-1
37. Unii-zou145w1xl
38. Nsc 179197
39. Siqualone
40. Fluphenazine 2hcl
41. Prolixin (tn)
42. 2-(4-(3-(2-(trifluoromethyl)-10h-phenothiazin-10-yl)propyl)piperazin-1-yl)ethan-1-ol Dihydrochloride
43. 2-(4-{3-[2-(trifluoromethyl)-10h-phenothiazin-10-yl]propyl}piperazin-1-yl)ethan-1-ol Dihydrochloride
44. Prestwick_225
45. Fluphenazine Hydrochloride [usp:ban:jan]
46. Schembl41634
47. Spectrum1500994
48. Chebi:5126
49. Flufenazine Hydrochloride
50. Chembl1448187
51. Dtxsid00892922
52. Hms1568p22
53. Hms1921o14
54. Bcp18079
55. Hy-a0081
56. Tox21_500555
57. S4569
58. Fluphenazine Hydrochloride (jan/usp)
59. Akos015960787
60. Ccg-212902
61. Cs-4290
62. Lp00555
63. 1-piperazineethanol, 4-(3-(2-(trifluoromethyl)phenothiazin-10-yl)propyl)-, Dihydrochloride
64. Fluphenazine Hydrochloride [jan]
65. Fluphenazine Dihydrochloride [mi]
66. Ncgc00093941-01
67. Ncgc00093941-02
68. Ncgc00093941-03
69. Ncgc00261240-01
70. Ac-12201
71. Bs-15804
72. Fluphenazine Hydrochloride [mart.]
73. Fluphenazine Hydrochloride [vandf]
74. S4569 Fluphenazine (dihydrochloride).cd
75. Fluphenazine Hydrochloride [usp-rs]
76. Fluphenazine Hydrochloride [who-dd]
77. Fluphenazine Hydrochloride [who-ip]
78. Eu-0100555
79. F1240
80. Ft-0668755
81. C72785
82. D00791
83. F 4765
84. Fluphenazine Hydrochloride [orange Book]
85. Fluphenazine Hydrochloride [usp Impurity]
86. Fluphenazine Hydrochloride [usp Monograph]
87. Fluphenazini Hydrochloridum [who-ip Latin]
88. Sr-01000003048-2
89. Sr-01000003048-9
90. W-108125
91. Fluphenazine Dihydrochloride 100 Microg/ml In Methanol
92. Q27295826
93. Z2784093501
94. Fluphenazine Dihydrochloride 1.0 Mg/ml In Methanol (as Free Base)
95. Fluphenazine Dihydrochloride, European Pharmacopoeia (ep) Reference Standard
96. Fluphenazine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
97. Fluphenazine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
98. 2-(4-(3-(2-(trifluoromethyl)-10h-phenothiazin-10-yl)propyl)piperazin-1-yl)ethanoldihydrochloride
99. 2-(4-{3-[2-(trifluoromethyl)-10h-phenothiazin-10-yl]propyl}-1-piperazinyl)ethanol Dihydrochloride
100. 2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol,dihydrochloride
101. Fluphenazine Dihydrochloride Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
Molecular Weight | 510.4 g/mol |
---|---|
Molecular Formula | C22H28Cl2F3N3OS |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 6 |
Exact Mass | 509.1282236 g/mol |
Monoisotopic Mass | 509.1282236 g/mol |
Topological Polar Surface Area | 55.2 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 544 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Fluphenazine hydrochloride |
PubMed Health | Fluphenazine Hydrochloride (By mouth) |
Drug Classes | Analgesic, Antipsychotic |
Drug Label | Fluphenazine hydrochloride is a trifluoromethyl phenothiazine derivative intended for the management of schizophrenia. Chemically it is 4-[3-[2-(Trifluoromethyl) phenothiazin-10-yl]propyl]-1-piperazineethanol dihydrochloride which may be represented... |
Active Ingredient | Fluphenazine hydrochloride |
Dosage Form | Elixir; Tablet; Concentrate; Injectable |
Route | Injection; Oral |
Strength | 2.5mg; 1mg; 2.5mg/ml; 2.5mg/5ml; 5mg; 5mg/ml; 10mg |
Market Status | Prescription |
Company | Pharm Assoc; Sandoz; Fresenius Kabi Usa; Lannett; Mylan |
2 of 2 | |
---|---|
Drug Name | Fluphenazine hydrochloride |
PubMed Health | Fluphenazine Hydrochloride (By mouth) |
Drug Classes | Analgesic, Antipsychotic |
Drug Label | Fluphenazine hydrochloride is a trifluoromethyl phenothiazine derivative intended for the management of schizophrenia. Chemically it is 4-[3-[2-(Trifluoromethyl) phenothiazin-10-yl]propyl]-1-piperazineethanol dihydrochloride which may be represented... |
Active Ingredient | Fluphenazine hydrochloride |
Dosage Form | Elixir; Tablet; Concentrate; Injectable |
Route | Injection; Oral |
Strength | 2.5mg; 1mg; 2.5mg/ml; 2.5mg/5ml; 5mg; 5mg/ml; 10mg |
Market Status | Prescription |
Company | Pharm Assoc; Sandoz; Fresenius Kabi Usa; Lannett; Mylan |
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
Dopamine Antagonists
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
Century has been an API manufacturer for over 40 years & is the partner of choice for multipurpose custom manufacturing projects.
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-10-16
Pay. Date : 2019-09-23
DMF Number : 33949
Submission : 2019-07-27
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5648
Submission : 1984-12-07
Status : Active
Type : II
Available Reg Filing : ASMF |
NDC Package Code : 48954-468
Start Marketing Date : 1984-12-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-02-06
Pay. Date : 2016-11-30
DMF Number : 4126
Submission : 1981-02-27
Status : Active
Type : II
NDC Package Code : 46204-0002
Start Marketing Date : 2012-04-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-01-08
Pay. Date : 2018-11-27
DMF Number : 33371
Submission : 2018-11-29
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-12-01
Pay. Date : 2020-09-29
DMF Number : 33724
Submission : 2019-03-29
Status : Active
Type : II
Certificate Number : R0-CEP 2021-112 - Rev 00
Issue Date : 2023-06-14
Type : Chemical
Substance Number : 904
Status : Valid
Date of Issue : 2022-08-08
Valid Till : 2025-08-08
Written Confirmation Number : WC-0383
Address of the Firm :
NDC Package Code : 69766-068
Start Marketing Date : 2019-03-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35695
Submission : 2021-03-27
Status : Active
Type : II
Date of Issue : 2022-09-19
Valid Till : 2025-07-02
Written Confirmation Number : WC-0119
Address of the Firm :
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-07-28
Pay. Date : 2020-06-23
DMF Number : 33885
Submission : 2019-08-30
Status : Active
Type : II
NDC Package Code : 42413-0202
Start Marketing Date : 2019-09-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-11-12
Pay. Date : 2021-09-27
DMF Number : 36326
Submission : 2021-09-23
Status : Active
Type : II
Certificate Number : CEP 2022-124 - Rev 01
Issue Date : 2023-10-19
Type : Chemical
Substance Number : 904
Status : Valid
Date of Issue : 2022-06-08
Valid Till : 2025-06-25
Written Confirmation Number : WC-0107
Address of the Firm :
Century has been an API manufacturer for over 40 years & is the partner of choice for multipurpose custom manufacturing projects.
About the Company : Century Pharmaceuticals, established in 1982, has 40 years of experience in manufacturing APIs. It has been supplying APIs produced in-house to several major pharma companies in In...
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
About the Company : Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-appro...
About the Company : Aspen API is the cooperative entity formed by Aspen Oss in the Netherlands and Fine Chemicals Corporation in South Africa. With quality, compliance, and teamwork at its core, Aspen...
About the Company : Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutica...
About the Company : Aurore Life Sciences is a pure-play API manufacturer with a diverse portfolio of capabilities in delivering efficiencies to generic players globally. Founded in 2017 by a team with...
About the Company : Centaur accepts change as a constant, and continuously innovates to remain significant. Centaur has built knowledge sharing relationships with the pharmaceutical majors in areas of...
About the Company : Enaltec Labs was established in 2006 by a group of young & experienced professionals with the specific objective to develop & produce complex, small volume, technology driven produ...
About the Company : Established in 1984, R L Fine Chem Pvt. Ltd. is one of the fastest growing API companies, with a leadership position in several APIs such as antihistamines, antidepressants and mus...
About the Company : Founded by a group of highly committed Technocrats in year 2009, today Raks Pharma is a partner of choice for pharmaceutical companies across the globe to source Active Pharmaceuti...
About the Company : TRIFARMA S.p.A. is an international and independent Group with the Mission to develop, manufacture and supply worldwide high quality APIs (Active Pharmaceutical Ingredients) to the...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
The launch of Fluphenazine Hydrochloride Tablets, USP, a therapeutic equivalent generic version of Prolixin Tablets, 1 mg, 2.5 mg, 5 mg, and 10 mg, which is approved by the U.S. Food and Drug Administration (USFDA).
Lead Product(s): Fluphenazine
Therapeutic Area: Psychiatry/Psychology Brand Name: Fluphenazine Hydrochloride-Generic
Study Phase: Approved FDFProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable February 18, 2021
Lead Product(s) : Fluphenazine
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : The launch of Fluphenazine Hydrochloride Tablets, USP, a therapeutic equivalent generic version of Prolixin Tablets, 1 mg, 2.5 mg, 5 mg, and 10 mg, which is approved by the U.S. Food and Drug Administration (USFDA).
Product Name : Fluphenazine Hydrochloride-Generic
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 18, 2021
Details:
Fluphenazine hydrochloride Tablets are a generic version of the brand product, Prolixin. Company has launched Fluphenazine Hydrochloride Tablets, USP in four strengths, 1 mg, 2.5 mg, 5 mg, and 10 mg.
Lead Product(s): Fluphenazine
Therapeutic Area: Psychiatry/Psychology Brand Name: Prolixin-Generic
Study Phase: Approved FDFProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable March 04, 2023
Lead Product(s) : Fluphenazine
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Upsher-Smith Launches Fluphenazine Hydrochloride Tablets
Details : Fluphenazine hydrochloride Tablets are a generic version of the brand product, Prolixin. Company has launched Fluphenazine Hydrochloride Tablets, USP in four strengths, 1 mg, 2.5 mg, 5 mg, and 10 mg.
Product Name : Prolixin-Generic
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 04, 2023
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
41
PharmaCompass offers a list of Fluphenazine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fluphenazine manufacturer or Fluphenazine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fluphenazine manufacturer or Fluphenazine supplier.
PharmaCompass also assists you with knowing the Fluphenazine API Price utilized in the formulation of products. Fluphenazine API Price is not always fixed or binding as the Fluphenazine Price is obtained through a variety of data sources. The Fluphenazine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Anatensol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Anatensol, including repackagers and relabelers. The FDA regulates Anatensol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Anatensol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Anatensol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Anatensol supplier is an individual or a company that provides Anatensol active pharmaceutical ingredient (API) or Anatensol finished formulations upon request. The Anatensol suppliers may include Anatensol API manufacturers, exporters, distributors and traders.
click here to find a list of Anatensol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Anatensol DMF (Drug Master File) is a document detailing the whole manufacturing process of Anatensol active pharmaceutical ingredient (API) in detail. Different forms of Anatensol DMFs exist exist since differing nations have different regulations, such as Anatensol USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Anatensol DMF submitted to regulatory agencies in the US is known as a USDMF. Anatensol USDMF includes data on Anatensol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Anatensol USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Anatensol suppliers with USDMF on PharmaCompass.
A Anatensol CEP of the European Pharmacopoeia monograph is often referred to as a Anatensol Certificate of Suitability (COS). The purpose of a Anatensol CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Anatensol EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Anatensol to their clients by showing that a Anatensol CEP has been issued for it. The manufacturer submits a Anatensol CEP (COS) as part of the market authorization procedure, and it takes on the role of a Anatensol CEP holder for the record. Additionally, the data presented in the Anatensol CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Anatensol DMF.
A Anatensol CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Anatensol CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Anatensol suppliers with CEP (COS) on PharmaCompass.
A Anatensol written confirmation (Anatensol WC) is an official document issued by a regulatory agency to a Anatensol manufacturer, verifying that the manufacturing facility of a Anatensol active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Anatensol APIs or Anatensol finished pharmaceutical products to another nation, regulatory agencies frequently require a Anatensol WC (written confirmation) as part of the regulatory process.
click here to find a list of Anatensol suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Anatensol as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Anatensol API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Anatensol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Anatensol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Anatensol NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Anatensol suppliers with NDC on PharmaCompass.
Anatensol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Anatensol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Anatensol GMP manufacturer or Anatensol GMP API supplier for your needs.
A Anatensol CoA (Certificate of Analysis) is a formal document that attests to Anatensol's compliance with Anatensol specifications and serves as a tool for batch-level quality control.
Anatensol CoA mostly includes findings from lab analyses of a specific batch. For each Anatensol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Anatensol may be tested according to a variety of international standards, such as European Pharmacopoeia (Anatensol EP), Anatensol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Anatensol USP).